Summary & Overview
HCPCS A7023: Nasal Mechanical Allergen Barrier Cream
HCPCS Level II code A7023 identifies a topical nasal mechanical allergen particle barrier or inhalation filter formulated as a cream. This code matters nationally as it standardizes billing for a non-invasive preventive product intended to reduce exposure to airborne allergens at the anterior nasal cavity, supporting allergic rhinitis management and environmental control strategies.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical purpose, the typical service setting, and how major payers approach coverage and billing for device-like topical products. The publication also summarizes common billing modifiers associated with comparable HCPCS items where applicable, and highlights what information is available and what is not (for example, associated taxonomies and ICD-10 pairings are not provided in the input).
This piece provides a practical reference for billing staff, compliance officers, and policy analysts: it explains what A7023 represents, clarifies the expected site of service, and outlines the scope of payer consideration. Data not available in the input (such as specific coverage policies or fee benchmarks) is noted as unavailable, so readers should consult payer policy documents for definitive coverage determinations.
Billing Code Overview
HCPCS Level II code A7023 describes a mechanical allergen particle barrier/inhalation filter, cream, nasal, topical. This item is a topical nasal product intended to create a physical barrier against airborne allergens and particulates at the nasal mucosa.
-
Service type: Topical nasal barrier product
-
Typical site of service: Ambulatory care settings and outpatient clinics where over-the-counter or device-supportive topical nasal therapies are provided; may also be used in home settings following clinician recommendation
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with seasonal or perennial allergic rhinitis who seeks nonpharmacologic symptomatic relief and wishes to reduce inhaled allergen exposure. The clinician (an allergist, otolaryngologist, primary care physician, or pharmacist in jurisdictions permitting point-of-care dispensing) assesses nasal symptoms, reviews prior therapies, and documents medical necessity for a topical mechanical allergen particle barrier/inhalation filter delivered as a cream applied intranasally. The workflow includes medical history and focused nasal exam, documentation of allergy diagnosis (for example, allergic rhinitis with or without conjunctivitis), discussion of therapy options, provision or prescription of the device, instruction on application technique and frequency, and follow-up assessment for symptom response and any local adverse effects. Typical sites of service are outpatient clinic settings, allergy or ENT offices, urgent care centers, and occasionally retail pharmacy when dispensed directly to the patient.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to furnish the topical nasal barrier is substantially greater than usual (extensive counseling, complex application technique training, or additional documented work). |
23 |